Mpm Bioventures 2014, L.p. - Net Worth and Insider Trading

Mpm Bioventures 2014, L.p. Net Worth

The estimated net worth of Mpm Bioventures 2014, L.p. is at least $354 Million dollars as of 2024-06-02. Mpm Bioventures 2014, L.p. is the 10% Owner of ITeos Therapeutics Inc and owns about 13,822,380 shares of ITeos Therapeutics Inc (ITOS) stock worth over $231 Million. Mpm Bioventures 2014, L.p. is the 10% Owner of Entrada Therapeutics Inc and owns about 4,425,784 shares of Entrada Therapeutics Inc (TRDA) stock worth over $68 Million. Mpm Bioventures 2014, L.p. is also the of Harpoon Therapeutics Inc and owns about 1,611,361 shares of Harpoon Therapeutics Inc (HARP) stock worth over $37 Million. Besides these, Mpm Bioventures 2014, L.p. also holds Repare Therapeutics Inc (RPTX) , TCR2 Therapeutics Inc (TCRR) , Oncorus Inc (ONCR) . Details can be seen in Mpm Bioventures 2014, L.p.'s Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mpm Bioventures 2014, L.p. has not made any transactions after 2022-01-05 and currently still holds the listed stock(s).

Transaction Summary of Mpm Bioventures 2014, L.p.

To

Mpm Bioventures 2014, L.p. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mpm Bioventures 2014, L.p. owns 7 companies in total, including Oncorus Inc (ONCR) , ITeos Therapeutics Inc (ITOS) , and Repare Therapeutics Inc (RPTX) among others .

Click here to see the complete history of Mpm Bioventures 2014, L.p.’s form 4 insider trades.

Insider Ownership Summary of Mpm Bioventures 2014, L.p.

Ticker Comapny Transaction Date Type of Owner
ONCR Oncorus Inc 2020-10-06 10 percent owner
ITOS ITeos Therapeutics Inc 2022-01-05 10 percent owner
RPTX Repare Therapeutics Inc 2020-06-23 10 percent owner
LIMIT LIMIT 2019-02-19 10 percent owner
LIMIT LIMIT 2021-04-15 10 percent owner
LIMIT LIMIT 2021-11-02 10 percent owner
LIMIT LIMIT 2021-04-29 10 percent owner

Mpm Bioventures 2014, L.p. Latest Holdings Summary

Mpm Bioventures 2014, L.p. currently owns a total of 6 stocks. Among these stocks, Mpm Bioventures 2014, L.p. owns 13,822,380 shares of ITeos Therapeutics Inc (ITOS) as of January 5, 2022, with a value of $231 Million and a weighting of 65.41%. Mpm Bioventures 2014, L.p. owns 4,425,784 shares of Entrada Therapeutics Inc (TRDA) as of November 2, 2021, with a value of $68 Million and a weighting of 19.35%. Mpm Bioventures 2014, L.p. also owns 1,611,361 shares of Harpoon Therapeutics Inc (HARP) as of April 15, 2021, with a value of $37 Million and a weighting of 10.48%. The other 3 stocks Repare Therapeutics Inc (RPTX) , TCR2 Therapeutics Inc (TCRR) , Oncorus Inc (ONCR) have a combined weighting of 4.76% among all his current holdings.

Latest Holdings of Mpm Bioventures 2014, L.p.

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ITOS ITeos Therapeutics Inc 2022-01-05 13,822,380 16.75 231,455,753
TRDA Entrada Therapeutics Inc 2021-11-02 4,425,784 15.47 68,466,878
HARP Harpoon Therapeutics Inc 2021-04-15 1,611,361 23.01 37,077,417
RPTX Repare Therapeutics Inc 2020-06-23 3,003,772 3.50 10,498,183
TCRR TCR2 Therapeutics Inc 2019-02-19 4,050,865 1.48 5,995,280
ONCR Oncorus Inc 2020-10-06 2,849,453 0.13 359,031

Holding Weightings of Mpm Bioventures 2014, L.p.


Mpm Bioventures 2014, L.p. Form 4 Trading Tracker

According to the SEC Form 4 filings, Mpm Bioventures 2014, L.p. has made a total of 20 transactions in ITeos Therapeutics Inc (ITOS) over the past 5 years, including 2 buys and 18 sells. The most-recent trade in ITeos Therapeutics Inc is the sale of 146,685 shares on January 5, 2022, which brought Mpm Bioventures 2014, L.p. around $6 Million.

According to the SEC Form 4 filings, Mpm Bioventures 2014, L.p. has made a total of 1 transactions in Entrada Therapeutics Inc (TRDA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Entrada Therapeutics Inc is the acquisition of 100,000 shares on November 2, 2021, which cost Mpm Bioventures 2014, L.p. around $2 Million.

According to the SEC Form 4 filings, Mpm Bioventures 2014, L.p. has made a total of 7 transactions in Harpoon Therapeutics Inc (HARP) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Harpoon Therapeutics Inc is the sale of 467 shares on April 15, 2021, which brought Mpm Bioventures 2014, L.p. around $94,067.

More details on Mpm Bioventures 2014, L.p.'s insider transactions can be found in the Insider Trading History of Mpm Bioventures 2014, L.p. table.

Insider Trading History of Mpm Bioventures 2014, L.p.

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mpm Bioventures 2014, L.p. Trading Performance

GuruFocus tracks the stock performance after each of Mpm Bioventures 2014, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mpm Bioventures 2014, L.p. is 10.7%. GuruFocus also compares Mpm Bioventures 2014, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Mpm Bioventures 2014, L.p. within 3 months outperforms 3 times out of 7 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Mpm Bioventures 2014, L.p.'s insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Mpm Bioventures 2014, L.p.

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
3 out of 7 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 20.86 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 16.83 LIMIT LIMIT LIMIT LIMIT LIMIT

Mpm Bioventures 2014, L.p. Ownership Network

Ownership Network List of Mpm Bioventures 2014, L.p.

No Data

Ownership Network Relation of Mpm Bioventures 2014, L.p.

Insider Network Chart

Mpm Bioventures 2014, L.p. Owned Company Details

What does Oncorus Inc do?

Who are the key executives at Oncorus Inc?

Mpm Bioventures 2014, L.p. is the 10 percent owner of Oncorus Inc. Other key executives at Oncorus Inc include Interim CEO Brian J. Shea , Interim CFO Alexander Nolte , and director & 10 percent owner & other: *Possible Member of 10% Group James E Flynn .

Oncorus Inc (ONCR) Insider Trades Summary

Over the past 18 months, Mpm Bioventures 2014, L.p. made no insider transaction in Oncorus Inc (ONCR). Other recent insider transactions involving Oncorus Inc (ONCR) include a net sale of 551,663 shares made by James E Flynn ,

In summary, during the past 3 months, insiders sold 0 shares of Oncorus Inc (ONCR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 551,663 shares of Oncorus Inc (ONCR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 551,663 shares.

Oncorus Inc (ONCR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Oncorus Inc Insider Transactions

No Available Data

Mpm Bioventures 2014, L.p. Mailing Address

Above is the net worth, insider trading, and ownership report for Mpm Bioventures 2014, L.p.. You might contact Mpm Bioventures 2014, L.p. via mailing address: C/o Mpm Asset Management Llc, 450 Kendall Street, Cambridge Ma 02142.

Discussions on Mpm Bioventures 2014, L.p.

No discussions yet.